Fol. Biol. 2012, 58, 185-192
https://doi.org/10.14712/fb2012058050185
Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen
Crossref Cited-by Linking
- Ferguson Daniel C.J., Smerdon Gary R., Harries Lorna W., Dodd Nicholas J.F., Murphy Michael P., Curnow Alison, Winyard Paul G.: Altered cellular redox homeostasis and redox responses under standard oxygen cell culture conditions versus physioxia. Free Radical Biology and Medicine 2018, 126, 322. <https://doi.org/10.1016/j.freeradbiomed.2018.08.025>
- Tao Miaomiao, Chen Shu, Zhang Xianquan, Zhou Qi: Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer. Medicine 2017, 96, e9384. <https://doi.org/10.1097/MD.0000000000009384>
- Xianyu Chen, Chao He, Dongdong Han, Meirong Zhou, Quan Wang, Jinhui Tian, Lun Li, Feng Xu, Enxiang Zhou, Kehu Yang: The Predictive Value of Ki-67 Before Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Future Oncol. 2017, 13, 843. <https://doi.org/10.2217/fon-2016-0420>
- LIU Hui-Ying, LI Qing-Ran, CHENG Xue-Fang, WANG Guang-Ji, HAO Hai-Ping: NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells. Chinese Journal of Natural Medicines 2016, 14, 582. <https://doi.org/10.1016/S1875-5364(16)30068-1>
- Yang Dong, Chen Min-Bin, Wang Li-Qiang, Yang Lan, Liu Chao-Ying, Lu Pei-Hua: Bcl-2 expression predicts sensitivity to chemotherapy in breast cancer: a systematic review and meta-analysis. J Exp Clin Cancer Res 2013, 32. <https://doi.org/10.1186/1756-9966-32-105>